NCT05927493

Brief Summary

More than 80% of patients with upper gastrointestinal bleeding (UGIB) are hospitalized after their visit to the emergency department (ED). However, some of these hospitalizations do not seem justified. Several clinical scores have been developed to classify patients according to their risk of death or need for therapeutic intervention. The aims of this study are:

  1. 1.to describe the characteristics of patients hospitalized for UGIB after their visit to the ED
  2. 2.to assess the predictive factors of hospital intervention or death
  3. 3.to assess the accuracy of existing prognostic scores to classify patients according their risk of death or need for therapeutic intervention (external validation) and to identify low-risk patients not requiring intervention.
  4. 4.Depending on the results, a new score could be derived to identify patients at low risk for intervention or death.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

May 11, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 3, 2023

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

2.1 years

First QC Date

May 11, 2023

Last Update Submit

June 28, 2023

Conditions

Keywords

Upper gastrointestinal bleedingEmergency departmentLow-riskScores

Outcome Measures

Primary Outcomes (2)

  • Number of patients treated with specific therapeutic intervention

    Blood transfusion or endoscopic hemostasis or radiological hemostasis or surgical hemostasis in 7 days

    7 days

  • Number of deceased patients

    30 days

Secondary Outcomes (5)

  • Number of patients treated with blood transfusion(s)

    7 days

  • Number of patients treated with endoscopic hemostasis

    7 days

  • number of patients treated with endoscopic hemostasis

    7 days

  • number of patients treated with interventional radiology hemostasis

    7 days

  • Death

    30 days

Study Arms (1)

Upper gastrointestinal bleeding

Patients with upper gastrointestinal bleeding hospitalized after ED visit

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient ≥ 18 years old with a diagnosis of upper gastrointestinal bleeding hospitalized after an ED visit in hospital with data available in the Assistance Publique-Hôpitaux de Paris data warehouse

You may qualify if:

  • patient ≥ 18 years old
  • with a diagnosis of upper gastrointestinal bleeding (defined by ICD10 codes)
  • visited a hospital with ED data available in the data warehouse

You may not qualify if:

  • reason for consultation not related to upper gastrointestinal bleeding (identified by manual reading of hospital notes)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emergency department:Saint-Antoine Hospital

Paris, 75012, France

Location

MeSH Terms

Conditions

Gastrointestinal HemorrhageEmergencies

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Study Officials

  • Pierre-Clément THIEBAUD, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2023

First Posted

July 3, 2023

Study Start

January 1, 2019

Primary Completion

February 1, 2021

Study Completion

February 1, 2021

Last Updated

July 3, 2023

Record last verified: 2023-06

Locations